Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc....
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
Dear Devyser network, partners, and valued customers,
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
Devyser and Thermo Fisher Scientific have agreed to expand commercial collaboration by including...
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...
Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...
Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...
